chr17-81098211-A-G

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001144888.2(BAIAP2):​c.490-1717A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.246 in 1,357,926 control chromosomes in the GnomAD database, including 42,434 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.21 ( 4027 hom., cov: 32)
Exomes 𝑓: 0.25 ( 38407 hom. )

Consequence

BAIAP2
NM_001144888.2 intron

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.325
Variant links:
Genes affected
BAIAP2 (HGNC:947): (BAR/IMD domain containing adaptor protein 2) The protein encoded by this gene has been identified as a brain-specific angiogenesis inhibitor (BAI1)-binding protein. This adaptor protein links membrane bound G-proteins to cytoplasmic effector proteins. This protein functions as an insulin receptor tyrosine kinase substrate and suggests a role for insulin in the central nervous system. It also associates with a downstream effector of Rho small G proteins, which is associated with the formation of stress fibers and cytokinesis. This protein is involved in lamellipodia and filopodia formation in motile cells and may affect neuronal growth-cone guidance. This protein has also been identified as interacting with the dentatorubral-pallidoluysian atrophy gene, which is associated with an autosomal dominant neurodegenerative disease. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Jan 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.471 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BAIAP2NM_001144888.2 linkuse as main transcriptc.490-1717A>G intron_variant ENST00000428708.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BAIAP2ENST00000428708.7 linkuse as main transcriptc.490-1717A>G intron_variant 1 NM_001144888.2 A1Q9UQB8-2

Frequencies

GnomAD3 genomes
AF:
0.213
AC:
32421
AN:
151986
Hom.:
4030
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.117
Gnomad AMI
AF:
0.228
Gnomad AMR
AF:
0.224
Gnomad ASJ
AF:
0.280
Gnomad EAS
AF:
0.487
Gnomad SAS
AF:
0.235
Gnomad FIN
AF:
0.179
Gnomad MID
AF:
0.288
Gnomad NFE
AF:
0.248
Gnomad OTH
AF:
0.218
GnomAD3 exomes
AF:
0.252
AC:
13281
AN:
52750
Hom.:
1790
AF XY:
0.247
AC XY:
7414
AN XY:
29992
show subpopulations
Gnomad AFR exome
AF:
0.112
Gnomad AMR exome
AF:
0.231
Gnomad ASJ exome
AF:
0.266
Gnomad EAS exome
AF:
0.531
Gnomad SAS exome
AF:
0.230
Gnomad FIN exome
AF:
0.182
Gnomad NFE exome
AF:
0.245
Gnomad OTH exome
AF:
0.242
GnomAD4 exome
AF:
0.250
AC:
301961
AN:
1205820
Hom.:
38407
Cov.:
31
AF XY:
0.250
AC XY:
146739
AN XY:
586278
show subpopulations
Gnomad4 AFR exome
AF:
0.118
Gnomad4 AMR exome
AF:
0.231
Gnomad4 ASJ exome
AF:
0.274
Gnomad4 EAS exome
AF:
0.418
Gnomad4 SAS exome
AF:
0.237
Gnomad4 FIN exome
AF:
0.190
Gnomad4 NFE exome
AF:
0.251
Gnomad4 OTH exome
AF:
0.258
GnomAD4 genome
AF:
0.213
AC:
32430
AN:
152106
Hom.:
4027
Cov.:
32
AF XY:
0.209
AC XY:
15563
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.117
Gnomad4 AMR
AF:
0.224
Gnomad4 ASJ
AF:
0.280
Gnomad4 EAS
AF:
0.487
Gnomad4 SAS
AF:
0.235
Gnomad4 FIN
AF:
0.179
Gnomad4 NFE
AF:
0.248
Gnomad4 OTH
AF:
0.221
Alfa
AF:
0.231
Hom.:
1194
Bravo
AF:
0.216
Asia WGS
AF:
0.357
AC:
1237
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Attention deficit hyperactivity disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingClinical Genomics, Uppaluri K&H Personalized Medicine Clinic-Gene Variants in BAIAP2 have been studied in several populations and are known to cause ADHD. Potent variants of this gene prevent neuronal growth, maturation and survival, essential for proper functioning of frontal cortical and subcortical circuits. However, more clinical evidence is required to confer the association of this particular variant rs72634327 with Attention-deficit hyperactivity disorder. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.66
DANN
Benign
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72634327; hg19: chr17-79072011; API